SOLVA SURGERY
CYSGOD YR EGLWYS, SOLVA, HAVERFORDWESTStroke 12
The % of patients with a stroke shown to be non-haemorrhagic, or a history of TIA, who have a record that an anti-platelet agent (aspirin, clopidogrel, dipyridamole or a combination), or an anti-coagulant is being taken (unless a contraindication or side-effects are recorded)
Indicator | Year | Numerator | Denominator | Ratio | Centile |
---|---|---|---|---|---|
STROKE 9 | 2005 | 46 | 48 | 95.8% | |
STROKE 9 | 2006 | 43 | 46 | 93.5% | |
Stroke 12 | 2007 | 40 | 43 | 93.0% | |
Stroke 12 | 2008 | 39 | 40 | 97.5% | |
Stroke 12 | 2009 | 15 | 41 | 36.6% | |
Stroke 12 | 2010 | 37 | 38 | 97.4% | |
STROKE 12 | 2011 | 42 | 43 | 97.7% | |
STROKE 12 | 2012 | 49 | 50 | 98.0% | |
STROKE 12 | 2013 | 46 | 47 | 97.9% | |
STIA007W | 2014 | 43 | 43 | 100.0% | |
STIA007 | 2015 | 45 | 45 | 100.0% |